Prostate Cancer News on BioPortfolio

EMUC 2017 New data on prostate and urological cancers

Prof Nicholas James chairs a discussion with Prof Jeffrey Karnes and Prof Fred Witjes around the new data on treatment of prostate and other urological cancers presented at EMUC17.They discuss findings from the APCC consensus session at EMUC17 with a...

EMUC17 highlights Prostate cancer

Dr Jan Oldernburg and Mr Simon Brewster discuss their highlights from EMUC17 focusing on prostate cancer and presented posters from the conference.They discuss a prizewinning poster that looked into the management of patients with nonmetastatic...

Whole Pelvic Radiation ADT Limit Prostate Cancer Biochemical Failure

Whole pelvic radiation therapy WPRT and androgen deprivation therapy ADT reduce the risk of biochemical failure in men who receive postprostatectomy salvage radiotherapy for prostate cancer according to a database study. Reuters Health Information

AroCell AB Reporting period 1 July 30 September 2017

  AroCell AB publ Reporting period 1 July 30 September 2017 Net sales were 0 46 KSEK Losses after financial items were 3678 2590 KSEK Earnings per share were 0.12 0.09 SEK Cash flow from operating activities was 4227 784 KSEK Cash fl...

UVA aims to help patients with cancer make complex care decisions

University of Virginia Health System UVA is developing a tool to help patients with prostate cancer better understand the potential risks and rewards of their treatment options. The tool could help patients with other forms of cancer as well.

LIDDS Patent granted in India for prostate cancer treatment

LIDDS has received approval from the Indian patent office for its patent on "Method for treatment of prostate cancer and other prostate diseases" with the NanoZolid drug delivery technology formulation. The approved patent protects me...

Pages